30
Participants
Start Date
October 31, 2014
Primary Completion Date
December 31, 2021
Study Completion Date
August 31, 2024
DVC1-0101
The investigational product will be drawn into a disposable 1 mL syringe using a 23G needle. A total of 0.5 mL of investigational product will be injected intramuscularly into each administration site. After administration, the administration sites will be wrapped with dressings.
Matsuyama Red-Cross Hospital, Matsuyama
Kyushu University Hospital, Fukuoka
Kyushu Central Hospital, Fukuoka
Morinomiya Hospital, Osaka
Collaborators (1)
Ministry of Health, Labour and Welfare, Japan
OTHER_GOV
Japan Agency for Medical Research and Development
OTHER_GOV
Kyushu University
OTHER